Back

Single-dose replicating RNA vaccine induces neutralizing antibodies against SARS-CoV-2 in nonhuman primates

Erasmus, J. H.; Khandhar, A. P.; Walls, A. C.; Hemann, E. A.; O'Connor, M. A.; Murapa, P.; Archer, J.; Leventhal, S.; Fuller, J.; Lewis, T.; Draves, K. E.; Randall, S.; Guerriero, K. A.; Duthie, M. S.; Carter, D.; Reed, S. G.; Hawman, D. W.; Feldmann, H.; Gale, M.; Veesler, D.; Berglund, P.; Fuller, D. H.

2020-05-28 immunology
10.1101/2020.05.28.121640 bioRxiv
Show abstract

The ongoing COVID-19 pandemic, caused by infection with SARS-CoV-2, is having a dramatic and deleterious impact on health services and the global economy. Grim public health statistics highlight the need for vaccines that can rapidly confer protection after a single dose and be manufactured using components suitable for scale-up and efficient distribution. In response, we have rapidly developed repRNA-CoV2S, a stable and highly immunogenic vaccine candidate comprised of an RNA replicon formulated with a novel Lipid InOrganic Nanoparticle (LION) designed to enhance vaccine stability, delivery and immunogenicity. We show that intramuscular injection of LION/repRNA-CoV2S elicits robust anti-SARS-CoV-2 spike protein IgG antibody isotypes indicative of a Type 1 T helper response as well as potent T cell responses in mice. Importantly, a single-dose administration in nonhuman primates elicited antibody responses that potently neutralized SARS-CoV-2. These data support further development of LION/repRNA-CoV2S as a vaccine candidate for prophylactic protection from SARS-CoV-2 infection.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
npj Vaccines
○ 67 papers in training set
Top 0.1%
18.8%
Similar papers in this journal
2
Nature Communications
○ 5641 papers in training set
Top 8%
18.8%
Similar papers in this journal
3
Cell
○ 431 papers in training set
Top 1%
6.4%
Similar papers in this journal
4
Molecular Therapy
○ 81 papers in training set
Top 0.3%
5.6%
Similar papers in this journal
5
Cell Reports Medicine
○ 153 papers in training set
Top 0.6%
4.1%
Similar papers in this journal
50% of probability mass above
6
Cell Reports
○ 1498 papers in training set
Top 11%
3.6%
7
Science Translational Medicine
● 127 papers in training set
Top 1%
2.4%
8
iScience
○ 1154 papers in training set
Top 11%
2.4%
9
Nature Medicine
○ 125 papers in training set
Top 1%
2.2%
10
Science Advances
● 1243 papers in training set
Top 18%
1.9%
11
Science
● 477 papers in training set
Top 5%
1.8%
12
Frontiers in Immunology
○ 638 papers in training set
Top 6%
1.8%
13
Molecular Therapy - Methods & Clinical Development
○ 38 papers in training set
Top 0.4%
1.7%
14
Med
○ 39 papers in training set
Top 0.3%
1.5%
15
Scientific Reports
○ 3612 papers in training set
Top 58%
1.5%
16
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 32%
1.4%
17
ACS Central Science
● 71 papers in training set
Top 1%
1.1%
18
eBioMedicine
○ 183 papers in training set
Top 4%
1.1%
19
mBio
● 833 papers in training set
Top 9%
1.1%
20
eLife
● 5828 papers in training set
Top 58%
1.1%
21
Journal of Controlled Release
○ 44 papers in training set
Top 0.6%
1.1%
22
Immunity
○ 67 papers in training set
Top 1%
1.0%
23
Emerging Microbes & Infections
○ 74 papers in training set
Top 1%
0.9%
24
Science Immunology
● 88 papers in training set
Top 2%
0.9%
25
Nature
○ 645 papers in training set
Top 10%
0.9%
26
Microbiology Spectrum
● 469 papers in training set
Top 10%
0.9%
27
ACS Nano
● 113 papers in training set
Top 2%
0.6%
28
Vaccines
○ 198 papers in training set
Top 4%
0.6%
29
Cell Research
○ 51 papers in training set
Top 2%
0.6%
30
Nature Immunology
○ 79 papers in training set
Top 2%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.